SG11202107779SA - Diastereoisomerically enriched complex of gadolinium and of a pcta-based chelating ligand, and process for preparing and purifying same - Google Patents

Diastereoisomerically enriched complex of gadolinium and of a pcta-based chelating ligand, and process for preparing and purifying same

Info

Publication number
SG11202107779SA
SG11202107779SA SG11202107779SA SG11202107779SA SG11202107779SA SG 11202107779S A SG11202107779S A SG 11202107779SA SG 11202107779S A SG11202107779S A SG 11202107779SA SG 11202107779S A SG11202107779S A SG 11202107779SA SG 11202107779S A SG11202107779S A SG 11202107779SA
Authority
SG
Singapore
Prior art keywords
pcta
gadolinium
preparing
chelating ligand
based chelating
Prior art date
Application number
SG11202107779SA
Other languages
English (en)
Inventor
Greneur Soizic Le
Alain Chénedé
Martine Cerf
Myriam Petta
Emmanuelle Marais
Bruno François
Caroline Robic
Stéphanie Louguet
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of SG11202107779SA publication Critical patent/SG11202107779SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11202107779SA 2019-01-17 2020-01-17 Diastereoisomerically enriched complex of gadolinium and of a pcta-based chelating ligand, and process for preparing and purifying same SG11202107779SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
PCT/EP2020/051153 WO2020148436A1 (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
SG11202107779SA true SG11202107779SA (en) 2021-08-30

Family

ID=67001953

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107779SA SG11202107779SA (en) 2019-01-17 2020-01-17 Diastereoisomerically enriched complex of gadolinium and of a pcta-based chelating ligand, and process for preparing and purifying same

Country Status (27)

Country Link
US (2) US11590246B2 (sr)
EP (2) EP3902800B1 (sr)
JP (2) JP7071596B2 (sr)
KR (2) KR102438394B1 (sr)
CN (2) CN113735854B (sr)
AR (1) AR117835A1 (sr)
AU (1) AU2020208794B2 (sr)
BR (1) BR112021014006B1 (sr)
CA (1) CA3126268C (sr)
CL (1) CL2021001868A1 (sr)
CO (1) CO2021009261A2 (sr)
DK (2) DK3943493T3 (sr)
ES (2) ES2930136T3 (sr)
FI (1) FI3943493T3 (sr)
FR (1) FR3091873B1 (sr)
HR (2) HRP20230678T1 (sr)
HU (2) HUE060343T2 (sr)
IL (1) IL284884A (sr)
MA (2) MA55389A (sr)
MX (1) MX2021008651A (sr)
PL (2) PL3902800T3 (sr)
PT (2) PT3902800T (sr)
RS (1) RS64334B1 (sr)
SG (1) SG11202107779SA (sr)
TW (1) TWI811518B (sr)
WO (1) WO2020148436A1 (sr)
ZA (1) ZA202104994B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4151637A1 (en) 2018-08-06 2023-03-22 Bracco Imaging SPA Gadolinium bearing pcta-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
KR20230041007A (ko) * 2020-07-17 2023-03-23 게르브 Pcta로부터 유도된 킬레이팅 리간드의 제조 방법
EP4222861A1 (en) * 2020-10-02 2023-08-09 Eagle Harbor Technologies, Inc. Ion current droop compensation
WO2024049087A1 (ko) * 2022-09-01 2024-03-07 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) * 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
DK2988756T4 (da) * 2013-04-26 2022-08-08 Guerbet Sa Formulering af kontraststof og dertil knyttet fremstillingsfremgangsmåde
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
AU2018259992B2 (en) * 2017-04-28 2020-06-18 Otsuka Pharmaceutical Factory, Inc. Method for manufacturing diastereomer of citric acid derivative
EP4151637A1 (en) 2018-08-06 2023-03-22 Bracco Imaging SPA Gadolinium bearing pcta-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Also Published As

Publication number Publication date
HUE062554T2 (hu) 2023-11-28
JP7071596B2 (ja) 2022-05-19
HRP20221402T1 (hr) 2023-01-06
US20230149568A1 (en) 2023-05-18
MA55389A (fr) 2022-01-26
CA3126268A1 (fr) 2020-07-23
CL2021001868A1 (es) 2022-01-21
WO2020148436A1 (fr) 2020-07-23
FI3943493T3 (fi) 2023-07-19
AU2020208794A1 (en) 2021-08-05
HRP20230678T1 (hr) 2023-09-29
BR112021014006A2 (pt) 2021-09-21
ES2930136T3 (es) 2022-12-07
DK3902800T3 (da) 2022-11-28
US20220062443A1 (en) 2022-03-03
KR102502862B1 (ko) 2023-02-23
PT3943493T (pt) 2023-07-12
MA54626A (fr) 2022-04-20
CN113735854B (zh) 2024-05-14
CA3126268C (fr) 2024-01-09
JP2022508496A (ja) 2022-01-19
TWI811518B (zh) 2023-08-11
FR3091873A1 (fr) 2020-07-24
CO2021009261A2 (es) 2021-12-10
MX2021008651A (es) 2021-10-26
DK3943493T3 (da) 2023-07-24
FR3091873B1 (fr) 2020-12-25
ES2950118T3 (es) 2023-10-05
EP3943493A1 (fr) 2022-01-26
JP7321230B2 (ja) 2023-08-04
IL284884A (en) 2021-08-31
AU2020208794B2 (en) 2023-01-12
BR112021014006B1 (pt) 2023-05-02
EP3902800A1 (fr) 2021-11-03
US11590246B2 (en) 2023-02-28
KR102438394B1 (ko) 2022-09-01
JP2022009463A (ja) 2022-01-14
PL3902800T3 (pl) 2022-12-27
CN113646308A (zh) 2021-11-12
ZA202104994B (en) 2023-04-26
EP3943493B1 (fr) 2023-04-19
CN113735854A (zh) 2021-12-03
KR20210138134A (ko) 2021-11-18
AR117835A1 (es) 2021-08-25
EP3902800B1 (fr) 2022-09-07
RS64334B1 (sr) 2023-08-31
KR20210109039A (ko) 2021-09-03
TW202043227A (zh) 2020-12-01
PT3902800T (pt) 2022-11-16
PL3943493T3 (pl) 2023-08-07
HUE060343T2 (hu) 2023-02-28

Similar Documents

Publication Publication Date Title
SG11202107779SA (en) Diastereoisomerically enriched complex of gadolinium and of a pcta-based chelating ligand, and process for preparing and purifying same
ZA202104993B (en) Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched pcta and synthesis method
EP4199185A4 (en) METHOD FOR PURIFYING A NICKEL-COBALT-MANGANESE LEACH SOLUTION
IL282766A (en) Compounds that suppress factor XIa, kallikrein, methods for their production and their uses
HUE059586T2 (hu) Folyamatos eljárás nagy polimerizált etilén-oxid tartalmú poliéter-poliolok elõállítására kettõs fém-cianid katalizátor komplexum és egy magnézium-, 3-15. csoportú fém- vagy lantanoida sorozatú fémvegyület felhasználásával
PL3760748T3 (pl) Sposób otrzymywania zoptymalizowanych kalcynowanych peletek zawierających żelazo i chrom
SG11202100367PA (en) Gas purification filter, method for producing gas purification filter, and gas purification system
MY181661A (en) Catalyst preparation process
WO2009042683A3 (en) Time sequential processing operations
EP4051629C0 (en) PROCESS FOR PRODUCTION AND REGENERATION OF HYDROGEN-CARRYING COMPOUNDS
SG10201911539PA (en) A filter for treating ammonia nitrogen sewage
EP3914571C0 (de) Pulverförmiger, polymermodifizierter zusatzstoff für beton und verfahren zur herstellung eines betons
EP3946140A4 (en) AUTOMATED PROCESS FOR REUSING AN INTERMEDIATE ORTHODONTIC DIGITAL SETUP DUE TO TREATMENT PLAN CHANGES
SG10201802272SA (en) Simulated moving bed xylenes separation process, and optimized operating conditions for units treating paraxylene-rich feeds
IL291991B2 (en) (6Z,9Z)-9,6-dodecadiene-1-ine and a process for its preparation
ZA202106376B (en) Process for preparing a fused tricyclic compound, and intermediate thereof
GB202307745D0 (en) Process for the selective removal of anionic radionuclides
HUE063160T2 (hu) Porított, polimerrel modifikált adalékanyag betonhoz és eljárás beton készítésére
GB201916301D0 (en) method, apparatus & system for treating a skin condition
PL3628753T3 (pl) Sposób przygotowania peletek zawierających żelazo i chrom
SG11202109718RA (en) Denitration catalyst, and production method therefor
GB201806124D0 (en) A filter for a deposition process,related methods, and products thereof